(Dd3) Venous Stent Und
Payments companies reported to CMS as associated with (Dd3) Venous Stent Und. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Dd3) Venous Stent Und, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Dd3) Venous Stent Und
These are the largest totals companies reported as associated with (Dd3) Venous Stent Und. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Erin Murphy | Charlotte, NC | Vascular Surgery | $700.80 |
| Tariq Haddadin | Johnson City, TN | Interventional Cardiology | $291.90 |
| Owen Sweis | Winfield, IL | Vascular & Interventional Radiology | $205.70 |
| Farah Al Khitan | Gadsden, AL | Interventional Cardiology | $190.14 |
| Mohannad Bisharat | Pampa, TX | Interventional Cardiology | $165.76 |
| John Shao | Irvington, NJ | Interventional Cardiology | $154.01 |
| Yazan Alkhouri | Tampa, FL | Interventional Cardiology | $152.74 |
| Majdi Ashchi | Jacksonville, FL | Cardiovascular Disease | $149.79 |
| Grant Scott | Springfield, MO | Vascular Surgery | $143.22 |
| Todd Simon | Prescott Valley, AZ | Vascular Surgery | $141.22 |
Prescribed (Dd3) Venous Stent Und?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.